Biophytis to Present at World Aging Festival

Biophytis SA 6-K Filing Summary
FieldDetail
CompanyBiophytis SA
Form Type6-K
Filed DateJul 17, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: conference-participation, biotechnology, aging-research

TL;DR

Biophytis is presenting at the World Aging Festival on July 8th, showcasing their aging research.

AI Summary

Biophytis S.A. announced on July 8, 2025, its participation in the 7th edition of the World Aging Festival. The company, headquartered at Sorbonne University in Paris, France, will present its research and development activities. This event focuses on aging and age-related diseases.

Why It Matters

Biophytis' participation highlights its focus on aging research and potential advancements in treatments for age-related diseases, which could impact the biotechnology sector.

Risk Assessment

Risk Level: low — This filing is a routine announcement of participation in a conference, with no new financial or operational information that would significantly alter risk.

Key Players & Entities

  • Biophytis S.A. (company) — Registrant
  • Stanislas Veillet (person) — Contact Person
  • Sorbonne University (company) — Company Address
  • July 8, 2025 (date) — Press Release Date
  • 7th edition of the World Agi (event) — Event Name

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K is a Report of Foreign Private Issuer filed by Biophytis S.A. to announce its participation in the 7th edition of the World Aging Festival.

When was the press release announcing participation issued?

The press release announcing Biophytis S.A.'s participation was issued on July 8, 2025.

Where is Biophytis S.A. headquartered?

Biophytis S.A. is headquartered at Sorbonne University, BC 9, Bâtiment A 4ème étage, 4 place Jussieu, 75005 Paris, France.

What is the Commission File Number for Biophytis S.A.?

The Commission File Number for Biophytis S.A. is 001-38974.

What type of company is Biophytis S.A. classified as by the SEC?

Biophytis S.A. is classified under Standard Industrial Classification code 2834, which is Pharmaceutical Preparations.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on July 17, 2025 by Stanislas Veillet regarding Biophytis SA.

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.